Mesa, L.E., Lutgen, P., Velez, I.D. and Segura, A.M. (2015) Artemisia annua L., Potential Source of Molecules with Pharmacological Activity in Human Diseases. American Journal of Phytomedicine and Clinical Therapeutics, 3, 436-450.

has been cited by the following article:

• TITLE: Effect of Artemisia annua (Asteraceae) Extracts on Hemolysis in Individuals with G6PD-Deficiency

  AUTHORS: Jescica Bonarck Sohou, Casimir Jiras Kpego Ligan, Salomon Ezechiel Mahougnon Fiogbe, Thierry Comlan Marc Medehouenou, Fifame Esperance Elvire Kougnimon, Casimir Dewanou Akpovi

  KEYWORDS: Artemisia annua, Infusion, Saponins, G6PD Deficiency, Hemolysis

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.3, March 25, 2024

  ABSTRACT: Individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency are susceptible to hemolytic anemia when exposed to pro-oxidant substances. This study investigates the hemolytic impact of Artemisia annua (A. annua) extracts in G6PD-deficient subjects through a mixed experimental approach. In the in vitro phase, red blood cells from G6PD-deficient individuals and rats induced with Dehydroepiandrosterone (DHEA) were exposed to various concentrations of A. annua infusion, with distilled water and physiological saline as positive and negative controls respectively. The in vivo study involved G6PD-deficient Wistar rats divided into three groups receiving A. annua infusion, quinine (positive control), and distilled water (negative control) via gavage. Blood samples were collected for biochemical and hematological analyses. Notably, at a 40% concentration of A. annua infusion, there was a significant increase in the hemolysis rate of G6PD-deficient red blood cells compared to controls (p A. annua exhibited elevated aspartate aminotransferase (129.25 ± 4.55 U/L vs. 80.09 ± 4.03 U/L; p A. annua infusion tested positive for saponins. These findings underscore the risk of hemolysis in G6PD-deficient individuals upon ingesting A. annua.